Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Wright Reports
Provider: Reuters Investment Profile
Provider: Shared Research Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

NanoCarrier Co Ltd Announces IND Application for Nanoplatin (NC-6004)

Sunday, 23 Jun 2013 07:00pm EDT 

NanoCarrier Co Ltd the Investigational New Drug Application (IND Application) has been submitted to the United States FDA (Food and Drug Administration) for conducting a Phase Ib/II Dose Escalation and Expansion Trial of Nanoplatin (NC-6004) in the United States. 

Company Quote

-54.0 -3.70%
21 Aug 2014